x

Coronavirus

Johnson & Johnson Has Begun a New Late-Stage Trial of Its Experimental COVID-19 Vaccine

November 17, 2020

NEW BRUNSWICK, N.J. — Johnson & Johnson has begun a new late-stage trial of its experimental COVID-19 vaccine, this time on a two-dose regimen.

J&J plans to give up to 30,000 people two doses of the vaccine. It’s been testing a one-dose regimen in a 60,000-person trial that began in late September and has enrolled nearly 10,000 volunteers so far.

In the new trial, volunteers will get either the vaccine or a dummy shot, then a second dose 57 days later, a company spokesman said Monday. That study is being conducted in the U.S., plus Belgium, Colombia, France, Germany, the Philippines, South Africa, Spain and the UK — locations chosen because they have a high incidence of COVID-19 and can start testing quickly.

The company said it’s being “extremely thorough”’ by testing multiple doses and dosing regimens to evaluate long-term effectiveness.

A small, early-stage study of the vaccine found it triggered a strong immune response and was well tolerated.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.

Video

Mitsotakis Addresses Boston College Graduation Ceremony

BOSTON - Greek Prime Minister Kyriakos Mitsotakis spoke at the 146th graduation ceremony of Boston College, held on Monday.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.